PCM
HCAT icon

Prelude Capital Management’s Health Catalyst HCAT Stock Holding History

Prelude Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18,227
Closed -$116K – 1389
2024
Q2 		$116K Sell
18,227
-54,608
-75% -$351K 0.01% 1085
2024
Q1 		$548K Buy
72,835
+47,946
+193% +$438K 0.03% 600
2023
Q4 		$230K Buy
+24,889
New +$203K 0.02% 873
2022
Q3 		– Sell
-16,581
Closed -$240K – 1709
2022
Q2 		$240K Buy
+16,581
New +$283K 0.01% 1197
2020
Q1 		– Sell
-300
Closed -$10K – 1661
2019
Q4 		$10K Buy
+300
New +$9.93K ﹤0.01% 1703

Other funds holding HCAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return